Abstract:Introduction: Peripheral arterial disease (PAD) is a critical concern, particularly in the context of an aging population and escalating risk factors such as diabetes, hypertension, and smoking. PAD leads to significant morbidity and disability, imposing considerable healthcare and economic burdens. A detailed understanding of the functional outcomes of revascularization is essential as it influences the choice of therapeutic strategies. This is crucial for the patient-doctor dialogue, enabling informed decisions based on the benefits, risks, and costs associated with each option. This study specifically examines the effectiveness of various revascularization methods for iliac occlusive disease by analyzing factors such as procedural success rates, complication frequencies, long-term patency, and patient quality of life. By evaluating these characteristics, the study aims to guide surgeons in selecting the most appropriate treatment approach in modern vascular surgery. Methods: A 10-year single-center retrospective analysis was conducted, examining 521 patients (580 interventions) from January 2009 to December 2018. Treatments included endovascular recanalization and stenting (endovascular treatment, EVT) (31.4%), hybrid surgical treatment (HST) (31.6%), and open surgical treatment (OST) (37.07%). The examined characteristics were primary patency, primary assisted patency, secondary patency, complications, and the degree of limb salvage. Results: The study assessed variables such as age, gender, diabetes, hypertension, dyslipidemia, smoking status, chronic kidney disease, and anesthesiological risk (American Society of Anesthesiologists (ASA) grade). Patency rates across the three methods were 92.4%, with thrombosis observed in 7.6% of cases. Assisted primary reconstructions, identified in the analysis, were few in number. Across the three revascularization strategies, a total of 41 interventions were undertaken to preserve the patency of the index reconstruction. In cases of chronic limb-threatening ischemia (CLTI), the probability of losing patency is higher and occurs earlier. OST showed the longest patency duration (471.7±71.5 days), and EVT demonstrated consistent primary patency. Complications were the highest in OST, including five perioperative mortalities. Survival analysis revealed significant differences in patency between treatment methods, with EVT and HST showing better outcomes compared to OST, particularly in patients with CLTI. Conclusion: By far, this is one of the largest studies done comparing all three revascularization strategies. Endovascular, surgical, and hybrid interventions should be considered complementary elements in the vascular surgeon's toolkit. However, in the presented study, endovascular and hybrid treatment appeared to produce better outcomes compared to open surgical treatment, especially in patients with CLTI. Keeping this in mind the surgeon should be able to provide a more optimal and personalized treatment for patients with chronic lower limb ischemia.

The Impact of Revascularization Strategy on Clinical Failure, Hemodynamic Failure and Chronic Limb Threatening Ischemia Symptoms in the BEST-CLI Trial

Perioperative complications following open or endovascular revascularization for chronic limb-threatening ischemia in the BEST-CLI Trial

Secondary interventions following open versus endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial

Surgery or Endovascular Therapy for Patients with Chronic Limb-threatening Ischemia Requiring Infrapopliteal Interventions

Characterization of Cardiovascular Serious Adverse Events after Bypass or Endovascular Revascularization for Limb Threatening Ischemia in the BEST-CLI Trial

Editor's Choice - Reduction of Major Amputations after Surgery versus Endovascular Intervention: The BEST-CLI Randomised Trial

The Impact of Diabetes Mellitus on the Outcomes of Revascularization for Chronic Limb-Threatening Ischemia in the BEST-CLI trial

Real-World Vein Mapping Practice Patterns Before Endovascular Treatment of Limb Ischemia

An endovascular- vs. a surgery-first revascularization strategy for chronic limb-threatening ischemia: A meta-analysis of randomized controlled trials

Abstract 16054: Comparing the Efficacy and Safety of Endovascular Therapy versus Surgical Revascularization for Critical Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis

Impact on Clinical Outcomes—An Observational Study

Relevance of BEST-CLI trial endpoints in a tertiary care limb preservation program

Short Term Outcomes of a Prospective Registry in Popliteal and Infrapopliteal Endovascular Interventions for Chronic Limb Threatening Ischaemia

Bypass Grafting vs Endovascular Therapy in Patients With Non-Dialysis-Dependent Chronic Kidney Disease and Chronic Limb-Threatening Ischemia (CRITISCH Registry)

Meta-Analysis of Randomised Controlled Trials Comparing Bypass and Endovascular Revascularisation for Peripheral Artery Disease

The Double Burden: Deciphering Chronic Limb-Threatening Ischemia in End-Stage Renal Disease

Network Meta-analysis of Randomised Controlled Trials Comparing the Outcomes of Different Endovascular Revascularisation Treatments for Infra-inguinal Peripheral Arterial Disease Causing Chronic Limb Threatening Ischaemia

Baseline modern medical management in the BEST-CLI trial

Outcomes for Patients With Chronic Limb-Threatening Ischemia After Direct and Indirect Endovascular and Surgical Revascularization: A Meta-Analysis and Systematic Review

Endovascular therapy for critical limb ischemia

A Decade of Progress: Assessing Three Revascularization Strategies for Iliac Occlusive Disease Through a 580-Case, 10-Year-Experience Literature Comparison